Literature DB >> 16397851

Composition and antimicrobial activity of Equisetum arvense L. essential oil.

Niko Radulović1, Gordana Stojanović, Radosav Palić.   

Abstract

The volatile constituents of the sterile stems of Equisetum arvense L. (Equisetaceae) were investigated for the first time using GC, GC/MS and (13)C-NMR. Twenty-five compounds were identified. Hexahydrofarnesyl acetone (18.34%), cis-geranyl acetone (13.74%), thymol (12.09%) and trans-phytol (10.06%) were the major constituents. A disk diffusion method was used for the evaluation of the antimicrobial activity of this oil against a panel of microorganisms (bacteria: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Salmonella enteritidis; fungi: Aspergillus niger and Candida albicans). The 1:10 dilution of the essential oil of Equisetum arvense L. was shown to possess a broad spectrum of a very strong antimicrobial activity against all tested strains. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397851     DOI: 10.1002/ptr.1815

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  21 in total

1.  Antioxidant, antimicrobial and genotoxicity screening of hydro-alcoholic extracts of five serbian Equisetum species.

Authors:  Vesna Milovanović; Niko Radulović; Zoran Todorović; Miroslava Stanković; Gordana Stojanović
Journal:  Plant Foods Hum Nutr       Date:  2007-08-04       Impact factor: 3.921

Review 2.  A review of the use of pteridophytes for treating human ailments.

Authors:  Xavier-Ravi Baskaran; Antony-Varuvel Geo Vigila; Shou-Zhou Zhang; Shi-Xiu Feng; Wen-Bo Liao
Journal:  J Zhejiang Univ Sci B       Date:  2018 Feb.       Impact factor: 3.066

3.  Equisetum arvense hydromethanolic extracts in bone tissue regeneration: in vitro osteoblastic modulation and antibacterial activity.

Authors:  C Bessa Pereira; P S Gomes; J Costa-Rodrigues; R Almeida Palmas; L Vieira; M P Ferraz; M A Lopes; M H Fernandes
Journal:  Cell Prolif       Date:  2012-06-01       Impact factor: 6.831

4.  Inhibition of human in vitro osteoclastogenesis by Equisetum arvense.

Authors:  J Costa-Rodrigues; S C Carmo; J C Silva; M H R Fernandes
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

5.  Prenatal exposure of a girl with autism spectrum disorder to 'horsetail' (Equisetum arvense) herbal remedy and alcohol: a case report.

Authors:  Juan A Ortega García; Mario G Angulo; Elías J Sobrino-Najul; Offie P Soldin; Alberto Puche Mira; Eduardo Martínez-Salcedo; Luz Claudio
Journal:  J Med Case Rep       Date:  2011-03-31

6.  The Beneficial Effect of Equisetum giganteum L. against Candida Biofilm Formation: New Approaches to Denture Stomatitis.

Authors:  Rafaela A S Alavarce; Luiz L Saldanha; Nara Ligia M Almeida; Vinicius C Porto; Anne L Dokkedal; Vanessa S Lara
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-28       Impact factor: 2.629

7.  The effect of equisetum arvense (horse tail) ointment on wound healing and pain intensity after episiotomy: a randomized placebo-controlled trial.

Authors:  Azam Asgharikhatooni; Soheila Bani; Shirin Hasanpoor; Sakineh Mohammad Alizade; Yousef Javadzadeh
Journal:  Iran Red Crescent Med J       Date:  2015-03-31       Impact factor: 0.611

8.  Phytomedical investigation of Najas minor All. in the view of the chemical constituents.

Authors:  Marina D Topuzovic; Ivana D Radojevic; Milan S Dekic; Niko S Radulovic; Sava M Vasic; Ljiljana R Comic; Braho Z Licina
Journal:  EXCLI J       Date:  2015-03-30       Impact factor: 4.068

9.  Cytotoxicity of Brazilian plant extracts against oral microorganisms of interest to dentistry.

Authors:  Jonatas Rafael de Oliveira; Vinicius Carlos de Castro; Polyana das Graças Figueiredo Vilela; Samira Esteves Afonso Camargo; Cláudio Antonio Talge Carvalho; Antonio Olavo Cardoso Jorge; Luciane Dias de Oliveira
Journal:  BMC Complement Altern Med       Date:  2013-08-15       Impact factor: 3.659

10.  Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.

Authors:  Victor Chedid; Sameer Dhalla; John O Clarke; Bani Chander Roland; Kerry B Dunbar; Joyce Koh; Edmundo Justino; Eric Tomakin; Gerard E Mullin
Journal:  Glob Adv Health Med       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.